KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Cash from Financing Activities (2016 - 2025)

LifeMD's Cash from Financing Activities history spans 14 years, with the latest figure at -$788562.0 for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 507.68% year-over-year to -$788562.0; the TTM value through Dec 2025 reached -$13.4 million, down 304.61%, while the annual FY2025 figure was -$13.4 million, 304.61% down from the prior year.
  • Cash from Financing Activities reached -$788562.0 in Q4 2025 per LFMD's latest filing, up from -$8.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $39.3 million in Q4 2021 to a low of -$8.7 million in Q3 2025.
  • Average Cash from Financing Activities over 5 years is $4.0 million, with a median of -$763737.5 recorded in 2022.
  • Peak YoY movement for Cash from Financing Activities: surged 1649.16% in 2023, then crashed 558.85% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $39.3 million in 2021, then crashed by 95.26% to $1.9 million in 2022, then soared by 671.21% to $14.4 million in 2023, then tumbled by 100.9% to -$129765.0 in 2024, then plummeted by 507.68% to -$788562.0 in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Cash from Financing Activities are -$788562.0 (Q4 2025), -$8.7 million (Q3 2025), and -$3.1 million (Q2 2025).